Phenobarbitone prophylaxis for neonatal jaundice in babies with birth weight 1000-1499 grams.
Management of neonatal jaundice is simple but in sick, very low birth weight babies poses additional hemodynamic insult. Role of prophylactic postnatal phenobarbitone (two different dosage regimens) was evaluated prospectively on occurrence of neonatal jaundice and the need for therapy in 150 babies with birth weight 1000-1499 grams. Phenobarbitone in the dose of 10mg/kg given within 6 hours of life followed by 5mg/kg/day till day 5 of life intravenously significantly decreased the need for exchange transfusion and duration of phototherapy in babies with birth weight of 1000-1499 grams. This dosage schedule was better than dose of 5mg/kg for 5 days in significantly reducing the duration of phototherapy
Kumar
Rajesh
R
Division of Neonatology, Department of Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Narang
Anil
A
Kumar
Praveen
P
Garewal
Gurjeevan
G
D005078:Exchange Transfusion, Whole Blood; D005260:Female; D006801:Humans; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D007567:Jaundice, Neonatal / Q000517:prevention & control*; D008297:Male; D010634:Phenobarbital / Q000627:therapeutic use*; D010789:Phototherapy; D011446:Prospective Studies
D010634:Phenobarbital